The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.

Condition	Treatment or Intervention	Phase
Behavior Therapy	Behavior: Behavior Therapy	Phase III

The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE).

This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Female

Criteria

Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.

Jennifer Manuel, Ph.D.      (212)740-3503    manuelj@pi.cpmc.columbia.edu

California
      BAART CDP, Los Angeles,  California,  90057,  United States; Not yet recruiting
Connecticut
      Hartford Dispensary, New Britain,  Connecticut,  06051,  United States; Recruiting
Maryland
      The Consortium, Philadelphia,  Maryland,  19104,  United States; Not yet recruiting
New York
      Staten Island University Hospital, Staten Island,  New York,  10309,  United States; Recruiting
North Carolina
      Addiction Drug Services, Greensboro,  North Carolina,  27401,  United States; Not yet recruiting
      South Light - Greensboro, Raleigh,  North Carolina,  27604,  United States; Not yet recruiting
      South Light - Wakeview, Raleigh,  North Carolina,  27604,  United States; Not yet recruiting
Ohio
      Comprehensive Addiction Services System, Toledo,  Ohio,  43620,  United States; Recruiting
Pennsylvania
      Thomas Jefferson Intensive Sub. Abuse TP, Philadelphia,  Pennsylvania,  19107,  United States; Recruiting
South Carolina
      LRADAC-Lexington-Richmond Alcohol & Drug Council, Columbia,  South Carolina,  29204,  United States; Recruiting
Washington
      Evergreen Treatment Services, Seattle,  Washington,  98134 1618,  United States; Recruiting
West Virginia
      Prestera Center for Mental Health Svcs., Huntington,  West Virginia,  25704,  United States; Recruiting

Study chairs or principal investigators

Susan Tross, Ph.D.,  Principal Investigator,  New York State Psychiatric Institute   

Study ID Numbers:  NIDA-CTN-0019-1
Record last reviewed:  November 2004
Record first received:  June 8, 2004
ClinicalTrials.gov Identifier:  NCT00084188
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08